fda_approval · anda · info
UNICHEM — ANDA approval: ALPRAZOLAM (unspecified)
- Event date
- 2026-07-13 00:00:00Z
- Observed
- 2026-07-18 04:30:40Z
- Source ID
- ANDA213204-1
- Payload hash
- bd88a909aca4aa42e9b95e3b…
Summary
UNICHEM received ANDA approval for ALPRAZOLAM (unspecified) on 2026-07-13. Dosage form: TABLET. Application #: ANDA213204.
Entities
Frequently asked questions
- Has UNICHEM had other FDA enforcement actions?
- This is the only FDA action Argus HQ has on file for UNICHEM as of 2026-07-18. Argus ingests new FDA enforcement records daily.
- What kind of FDA record is this?
- This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-13; Argus observed and indexed it on 2026-07-18.
- Where can I verify this record directly with FDA?
- The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
APA
Argus HQ Research (2026). UNICHEM — ANDA approval: ALPRAZOLAM (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-unichem-anda213204-1
MLA
"UNICHEM — ANDA approval: ALPRAZOLAM (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-unichem-anda213204-1.
Chicago
Argus HQ Research. "UNICHEM — ANDA approval: ALPRAZOLAM (unspecified)." Digital Empire Holdings LLC. Accessed July 18, 2026. https://argushq.ai/events/fda-approval-unichem-anda213204-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_unichem_anda213204_1_2026,
title = {UNICHEM — ANDA approval: ALPRAZOLAM (unspecified)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/events/fda-approval-unichem-anda213204-1},
note = {Accessed: July 18, 2026}
}Informational only. Not legal, financial, or medical advice.

